about
First detection of Onchocerca lupi infection in dogs in southern SpainTheileria annae (syn. Babesia microti-like) infection in dogs in NW Spain detected using direct and indirect diagnostic techniques: clinical report of 75 casesEfficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm.Epidemiological role of dogs since the human leishmaniosis outbreak in MadridThelazia callipaeda: infection in dogs: a new parasite for Spain.Detection and molecular characterization of Giardia duodenalis in children attending day care centers in Majadahonda, Madrid, Central Spain.DNA sequence analysis suggests that cytb-nd1 PCR-RFLP may not be applicable to sandfly species identification throughout the Mediterranean region.Current status of L. infantum infection in stray cats in the Madrid region (Spain): implications for the recent outbreak of human leishmaniosis?Randomized, allopurinol-controlled trial of the effects of dietary nucleotides and active hexose correlated compound in the treatment of canine leishmaniosis.Identification of Cryptosporidium subtype isolates from HIV-seropositive patients in Equatorial Guinea.LEISHMANIA INFANTUM INFECTION IN BENNETT'S WALLABIES (MACROPUS RUFOGRISEUS RUFOGRISEUS) IN A SPANISH WILDLIFE PARK.Course of experimental infection of canine leishmaniosis: follow-up and utility of noninvasive diagnostic techniques.First study on efficacy and tolerability of a new alkylphosphocholine molecule (oleylphosphocholine-OlPC) in the treatment of canine leishmaniosis due to Leishmania infantum.Modelling the current distribution and predicted spread of the flea species Ctenocephalides felis infesting outdoor dogs in Spain.Flea species infesting dogs in Spain: updated spatial and seasonal distribution patterns.Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations.Implications of zoonotic and vector-borne parasites to free-roaming cats in central Spain.Prevention of disease progression in Leishmania infantum-infected dogs with dietary nucleotides and active hexose correlated compound.Evaluation of the efficacy of a topically administered combination of imidacloprid and permethrin against Phlebotomus perniciosus in dog.First report of Leishmania infantum infection in the endangered orangutan (Pongo pygmaeus pygmaeus) in Madrid, Spain.Babesia microti-like piroplasm (syn. Babesia vulpes) infection in red foxes (Vulpes vulpes) in NW Spain (Galicia) and its relationship with Ixodes hexagonus.Detection of Thelazia callipaeda in Phortica variegata and spread of canine thelaziosis to new areas in Spain.Detection and molecular characterization of Acanthamoeba spp. in stray cats from Madrid, Spain.First description of naturally acquired Tritrichomonas foetus infection in a Persian cattery in Spain.A serological and molecular study of Leishmania infantum infection in cats from the Island of Ibiza (Spain).Comparison of nested PCR and real-time PCR for the detection of Toxoplasma gondii in biological samples from naturally infected cats.Detection of Toxoplasma gondii in cats by comparing bioassay in mice and polymerase chain reaction (PCR).Controlling phlebotomine sand flies to prevent canine Leishmania infantum infection: A case of knowing your enemyPrevalence and genotypes of Giardia duodenalis from dogs in Spain: possible zoonotic transmission and public health importanceThe role of healthy dog carriers of Babesia microti-like piroplasmsSurvey of intestinal parasites in stray dogs in the Madrid area and comparison of the efficacy of three anthelmintics in naturally infected dogsPrevalence of antibodies to Toxoplasma gondii and intestinal parasites in stray, farm and household cats in SpainEffect of two treatments on changes in serum acute phase protein concentrations in dogs with clinical leishmaniosis
P50
Q28833822-A3D5A6CF-B834-4684-8A30-C71639A27922Q33422140-8411311D-AEB2-41BE-807B-3A47D3C2E386Q33440113-4B04B69A-05D6-4070-A89C-DDC9873EF107Q33608778-3129CEF7-1F56-40D2-B5D9-B2A07AACDD78Q35172601-0B0B644B-C9F6-4A2E-BAD6-8EC05E48A799Q36193432-32CB0299-4AC7-4D83-8371-AB1507423CBCQ36594791-A7337274-BFDC-4EBD-9674-9EBD3EE946A3Q37714699-F84AE972-2F96-4F3D-B375-B03B5BF623B0Q38791374-52907CB8-8F57-4A2E-9362-BBA2568353E5Q38911599-81B91614-C20E-40F4-8CCE-7C44CC8A527BQ40596748-09C29DC1-16BF-4E64-A720-85EF66C07771Q41477493-9749AFA2-BFA0-45DD-B0AE-FDBEDC729D64Q44946324-BEE6C772-BA19-4262-AB32-794E1E333227Q46304358-F1E164AD-37F4-43F3-8DF7-DF947591BFA1Q46468723-E7B03FB9-1FB9-436A-853C-B5093CF4ED2EQ48032209-44C9D294-B57D-42C6-B3FE-AA508AB98493Q50093436-5E20BC93-BD5C-405A-9C80-FC12352768CAQ50328388-8DBD7C3B-BB95-48BC-93A8-339D58E85DA5Q51779351-DA3E1AB6-5A30-400A-8F13-92B1A1C8BF62Q51783447-0070501B-9975-4C96-A67F-BF22A0017F4CQ52646327-B28B7625-2A07-46E4-89DA-19C2C730F5D4Q52646428-60F49ABA-024F-46B5-8FBD-7A78A2CAB8C1Q54262780-C940CE12-E8E8-43F1-BD7D-2DCC8A75510BQ54376770-7FA6763E-8363-4916-B38F-DD6E3B3BD07EQ54413470-5399FA9F-60D7-4E49-BE1C-2B456FE2BF4CQ54434024-55178863-39D3-4127-9E12-F229CC9386A2Q54505535-A10F3F5D-3571-44E4-B168-83956B4FBFCFQ58568920-9564CBF1-5BC4-4201-B186-2E79998C3227Q58860178-89ACBAE9-FAC2-49C7-9367-607B7B566ED7Q64120699-484BA56F-7B69-4B46-BB1D-B4D17FA01292Q80130972-85FC9FC7-9220-48CE-BE56-09C3C727735FQ81066808-884DCA56-63CE-450F-965D-5ED50716677FQ92019165-7F56137B-3C77-4ED3-B013-DD7A77A8196D
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ana Montoya
@ast
Ana Montoya
@en
Ana Montoya
@es
Ana Montoya
@nl
type
label
Ana Montoya
@ast
Ana Montoya
@en
Ana Montoya
@es
Ana Montoya
@nl
prefLabel
Ana Montoya
@ast
Ana Montoya
@en
Ana Montoya
@es
Ana Montoya
@nl
P106
P1153
24475455800
P21
P31
P496
0000-0003-1911-8642